Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic

The rapid growth of 2019 novel coronavirus (COVID-19) outbreak in Wuhan, China, at the early December 2019. COVID-19 spread all over the word just a few months. The outbreak of COVID-19 infection poses major threat to international health and economy. World Health Organization (WHO) announced that t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li, Jiang, Man, Qu, Jialin, Zhou, Na, Zhang, Xiaochun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509820/
https://www.ncbi.nlm.nih.gov/pubmed/32983254
http://dx.doi.org/10.1186/s13027-020-00322-7
_version_ 1783585675465981952
author Wang, Li
Jiang, Man
Qu, Jialin
Zhou, Na
Zhang, Xiaochun
author_facet Wang, Li
Jiang, Man
Qu, Jialin
Zhou, Na
Zhang, Xiaochun
author_sort Wang, Li
collection PubMed
description The rapid growth of 2019 novel coronavirus (COVID-19) outbreak in Wuhan, China, at the early December 2019. COVID-19 spread all over the word just a few months. The outbreak of COVID-19 infection poses major threat to international health and economy. World Health Organization (WHO) announced that the new coronavirus was an international public health emergency on January 30, 2020. However, with the spread of COVID-19, the routine medical care of lung cancer patients was affected. Because lung cancer patients have low immunity after anti-tumor treatment, they should become the main targets for epidemic prevention. Lung cancer patients are increasingly concerned about the prevention of COVID-19. It is necessary to provide individualized medical treatment and management for lung cancer patients based on patients’ conditions and regional epidemic patterns.
format Online
Article
Text
id pubmed-7509820
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75098202020-09-23 Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic Wang, Li Jiang, Man Qu, Jialin Zhou, Na Zhang, Xiaochun Infect Agent Cancer Review The rapid growth of 2019 novel coronavirus (COVID-19) outbreak in Wuhan, China, at the early December 2019. COVID-19 spread all over the word just a few months. The outbreak of COVID-19 infection poses major threat to international health and economy. World Health Organization (WHO) announced that the new coronavirus was an international public health emergency on January 30, 2020. However, with the spread of COVID-19, the routine medical care of lung cancer patients was affected. Because lung cancer patients have low immunity after anti-tumor treatment, they should become the main targets for epidemic prevention. Lung cancer patients are increasingly concerned about the prevention of COVID-19. It is necessary to provide individualized medical treatment and management for lung cancer patients based on patients’ conditions and regional epidemic patterns. BioMed Central 2020-09-23 /pmc/articles/PMC7509820/ /pubmed/32983254 http://dx.doi.org/10.1186/s13027-020-00322-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Wang, Li
Jiang, Man
Qu, Jialin
Zhou, Na
Zhang, Xiaochun
Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic
title Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic
title_full Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic
title_fullStr Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic
title_full_unstemmed Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic
title_short Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic
title_sort clinical management of lung cancer patients during the outbreak of covid-19 epidemic
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509820/
https://www.ncbi.nlm.nih.gov/pubmed/32983254
http://dx.doi.org/10.1186/s13027-020-00322-7
work_keys_str_mv AT wangli clinicalmanagementoflungcancerpatientsduringtheoutbreakofcovid19epidemic
AT jiangman clinicalmanagementoflungcancerpatientsduringtheoutbreakofcovid19epidemic
AT qujialin clinicalmanagementoflungcancerpatientsduringtheoutbreakofcovid19epidemic
AT zhouna clinicalmanagementoflungcancerpatientsduringtheoutbreakofcovid19epidemic
AT zhangxiaochun clinicalmanagementoflungcancerpatientsduringtheoutbreakofcovid19epidemic

Ejemplares similares